Neuroimaging Correlates of 22q11.2 Deletion Syndrome: Implications for Schizophrenia Research

E. Boot*, T. A. M. J. van Amelsvoort

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


22q11.2 Deletion syndrome (22q11DS) is the most common known recurrent copy-number variant disorder. It is also the most common known genetic risk factor for schizophrenia. The greater homogeneity of subjects with schizophrenia in 22q11DS compared with schizophrenia in the wider non-deleted population may help to identify much needed information on neuroanatomical substrates, and neurochemical and neurofunctional mechanisms that may modulate the risk for schizophrenia. Identification of the underlying pathophysiology creates opportunities for developing genotype-specific, biology-based and targeted treatments to prevent, delay or minimize the severity of schizophrenia in both 22q11DS and the wider non-deleted population. This article reviews neuroimaging studies that focused on brain structure and function in this high-risk population, with particular attention to schizophrenia research. We also discuss the evidence on the role of candidate genes within the 22q11.2 region, with particular reference to catechol-O-methyl transferase (COMT) and proline dehydrogenase (PRODH).
Original languageEnglish
Pages (from-to)2303-2313
JournalCurrent Topics in Medicinal Chemistry
Issue number21
Publication statusPublished - Nov 2012


  • 22q11.2 Deletion syndrome
  • velocardiofacial syndrome
  • schizophrenia
  • psychosis
  • neuroimaging


Dive into the research topics of 'Neuroimaging Correlates of 22q11.2 Deletion Syndrome: Implications for Schizophrenia Research'. Together they form a unique fingerprint.

Cite this